Aztreonam Combination Therapy: An Answer to Metallo-β-Lactamase-Producing Gram-Negative Bacteria?

被引：42

作者：

Shields, Ryan K. ^{[1
,2
]}

Doi, Yohei ^{[1
,2
,3
,4
]}

机构：

[1] Univ Pittsburgh, Sch Med, Div Infect Dis, Pittsburgh, PA USA

[2] Univ Pittsburgh, Sch Med, Ctr Innovat Antimicrobial Therapy, Pittsburgh, PA USA

[3] Fujita Hlth Univ, Dept Microbiol, Toyoake, Aichi, Japan

[4] Fujita Hlth Univ, Dept Infect Dis, Toyoake, Aichi, Japan

来源：

CLINICAL INFECTIOUS DISEASES | 2020年 / 71卷 / 04期

基金：

美国国家卫生研究院;

关键词：

carbapenemase; monobactam; beta-lactamase inhibitor; pharmacokinetics; CEFTAZIDIME/AVIBACTAM; AVIBACTAM;

D O I：

10.1093/cid/ciz1159

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1099 / 1101

页数：3

共 25 条

[1]

BIAGI M, 2019, ANTIMICROB AGENTS CH, V2019

[2] Carbapenemase-Producing Organisms: A Global Scourge [J].

Bonomo, Robert A. ;

Burd, Eileen M. ;

Conly, John ;

Limbago, Brandi M. ;

Poirel, Laurent ;

Segre, Julie A. ;

Westblade, Lars F. .

CLINICAL INFECTIOUS DISEASES, 2018, 66 (08) :1290-1297

[3] Human Simulated Studies of Aztreonam and Aztreonam-Avibactam To Evaluate Activity against Challenging Gram-Negative Organisms, Including Metallo-β-Lactamase Producers [J].

Crandon, Jared L. ;

Nicolau, David P. .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (07) :3299-3306

[4] Pharmacokinetics and Pharmacodynamics of β-Lactamase Inhibitors [J].

Crass, Ryan L. ;

Pai, Manjunath P. .

PHARMACOTHERAPY, 2019, 39 (02) :182-195

[5] Ceftazidime-Avibactam and Aztreonam, an Interesting Strategy To Overcome β-Lactam Resistance Conferred by Metallo-β-Lactamases in Enterobacteriaceae and Pseudomonas aeruginosa [J].

Davido, Benjamin ;

Fellous, Lesly ;

Lawrence, Christine ;

Maxime, Virginie ;

Rottman, Martin ;

Dinh, Aurelien .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (09)

[6] New β-Lactamase Inhibitors: a Therapeutic Renaissance in an MDR World [J].

Drawz, Sarah M. ;

Papp-Wallace, Krisztina M. ;

Bonomo, Robert A. .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (04) :1835-1846

[7]

Emeraud C, 2019, ANTIMICROB AGENTS CH, V63, DOI [10.1128/AAC.00010-19, 10.1128/aac.00010-19]

[8] Successful Treatment of Bacteremia Due to NDM-1-Producing Morganella morganii with Aztreonam and Ceftazidime-Avibactam Combination in a Pediatric Patient with Hematologic Malignancy [J].

Hobson, Claire Amaris ;

Bonacorsi, Stephane ;

Fahd, Mony ;

Baruchel, Andre ;

Cointe, Aurelie ;

Poey, Nora ;

Jacquier, Herve ;

Doit, Catherine ;

Monjault, Audrey ;

Tenaillon, Olivier ;

Birgy, Andre .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (02)

[9] Carbapenemases in New York City: the continued decline of KPC-producing Klebsiella pneumoniae, but a new threat emerges [J].

Iregui, Alejandro ;

Ha, Karen ;

Meleney, Katharine ;

Landman, David ;

Quale, John .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (11) :2997-3000

[10]

Karlowsky JA, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00472-17, 10.1128/aac.00472-17]

← 1 2 3 →